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1. Introduction 
Because of their unusual spectral and catalytic 
properties, the cytochrome P-4.50 enzymes have been 
intensely investigated [ 11. A major objective has been 
to identify the non-porphyrin ligand(s) to the central 
iron in states l-5 of the P-450 reaction cycle (see 
Scheme 1). Comparative physical properties of syn- 
thetic porphyrin complexes with various axial ligands, 
myoglobin complexes with axial histidine ligation, 
and P450 reaction states 1,2 and 5 have provided 
convincing evidence for cysteinate ligation in the latter 
[2-91. Synthetic systems whose properties mimic 
those of reaction state 4 have not been prepared, 
making its axial ligand more difficult to ascertain. 
The identity of this ligand may be crucial for under- 
standing the dioxygen activation step (Scheme 1,4 + 1). 
Magnetic circular dichroism (MCD) spectroscopy 
has been particularly useful in studying the P-450 class 
of enzymes [5,8,10-171 because of its frequent ability 
to distinguish between porphyrin chromophores with 
different axial ligands. We have therefore obtained the 
MCD spectra of oxy-P-450, and of oxymyoglobin, 
the latter being a heme protein with known axial 
ligation by histidine. Substantial differences are seen, 
strongly suggesting the presence of an axial ligand in 
oxy-P-450_ other than neutral histidine. 
2. Methods 
Cytochrome P-450,, was isolated from the bac- 
terium Pseudomonas pufida [ 181 by a combination 
of the methods in [ 19,201. A spectral purity ratio 
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(Aa91/-4&) of 1.42 was obtained. Camphor-bound 
oxyP450,, was prepared as follows: 
i. Deaeration. 
ii. Reduction with NazSz04. 
iii. Cooling to -30°C. 
iv. Exposure to oxygen. 
Its absorption spectrum was nearly identical to 
[ 1,2 1,221. Oxymyoglobin was prepared in a similar 
fashion with omission of the initial deaeration step. 
Its MCD spectrum is quite similar to [23]. MCD mea- 
surements were obtained as in [ 141. The MCD spec- 
trum of oxyP-450,, shown in fig.1 has been cor- 
rected for the presence of a small amount (ca. 15%) of 
ferric, camphor-bound P450_ by subtraction of 
its contribution from the observed spectrum. A similar 
problem (S-IO% ferric contamination) was encoun- 
tered [23] in the preparation of oxymyoglobin. We 
have not corrected our MCD spectrum of oxymyo- 
globin for the presence of ferric myoglobin. These 
methods have been detailed [24]. 
3. Results 
The MCD spectra of oxyP450,, and of oxymyoglo- 
bin are shown in fig.1. The spectrum of oxymyoglobin 
is composed of three derivative-shaped curves with 
crossover points at 577 nm, 549 nm and 4 18 nm and 
an additional broad negative trough at 353 nm. The 
spectrum of oxy-P-450,, is noticeably more compli- 
cated with negative extrema at 587 nm, 56 1 run, 427 nm 
and 360 nm; crossover points at 569 nm, 557 nm, 
466 nm, 438 nm, 421 nm, 380 nm and 337 nm; and 
maxima at 533 nm, 446 nm, 407 nm and 327 run. 
4. Discussion 
oxyP450_ has previously been studied by optical 
absorption [ 1,21,22] and Mossbauer [25,26] spec- 
troscopy. These studies have clearly characterized it 
as an oxygenated ferrous hemeprotein. The identity 
of the axial ligand tram to dioxygen, however, is a 
matter of less certainty. This ligand may play an 
important role in modifying the reactivity of the iron 
in P-450 and giving rise to its unusual enzymic and 
spectral properties. The similarity in the Mossbauer 
and optical absorption properties of oxyP-450,, 
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Fig.1. Magnetic circular dichroism spectra at -30°C of: (a) top, 
oxygenated ferrous cytochrome P-4.50,,, in a 1:l mixture 
of ethylene glycol and 50 mM potassium phosphate buffer 
(pH 7.4, 100 mM KCI, 1 mM D-camphor); (b) bottom, 
oxygenated ferrous myoglobin in a 1:l mixture of ethylene 
glycol and 10 mM potassium phosphate buffer (pH 7.4). 
Please note that the scales are different for the two spectra. 
and oxyhemoglobin (and oxymyoglobin) makes it 
tempting to speculate that the axial ligand in P450_, 
is neutral histidine, as suggested [27]. There are, how- 
ever, important differences which make this assign- 
ment less likely. The temperature dependence of the 
Mossbauer quadrupole splitting is much stronger for 
oxyhemoglobin than for oxyP-450, [ 1,25,26]. 
Additionally [ 1,261, Mossbauer emission spectra of 
a series of oxygenated model heme complexes with 
various axial ligands trans to dioxygen [28] reveal that 
the technique is rather insensitive to the nature of the 
non-oxygen axial ligand bond. 
The optical absorption spectra of oxyP450,, 
and of oxymyoglobin, while similar in an overall 
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sense, also show important differences. The (Y and /3 
bands of oxyP-450,, (ca. 550 nm) are shifted in 
location and intensity relative to oxyhemoglobin (and 
oxymyoglobin) and have merged together as in [21]. 
A corresponding difference is seen in reduced +CO 
P-450 and myoglobin [ 1,6,29]. An additional differ- 
ence which has not been previously discussed, involves 
the near-ultraviolet 6 band (ca. 350 nm). In oxymyo- 
globin this band is at 348 nm with a millimolar extinc- 
tion coefficient of 26.2 [29], 20% of the value of 128 
for the Soret (y) band at 418 nm [29]. With oxy-P-450, 
the value for the 6 band at 355 nm is 37,60% of the 
Soret extinction coefficient of 62 at 418 nm 
[ I,2 1,22,30]. Thus the ratio of Soret to 6 band inten- 
sities changes as a result of enhancement of the 6 band 
by 40% and diminution of the Soret band by 52%. 
Again, analogous differences are seen between reduced 
+CO P-450 and hemoglobin [29,3 1,321. This intensity 
redistribution for reduced +CO P-450 has been dis- 
cussed [32] in terms of the presence of a charge 
transfer (sulfurpt + porphyrin e,(n)) transition which 
mixes with the Soret transition, stealing some of its 
intensity and shifting it to the red. With oxyP-450,,, 
the intensity shift is experimentally observed but the 
wavelength shift is not. Calculations [32] for the 
reduced +CO chromophore show that a thiolate anion 
can give rise to the required sulfur to porphyrin charge 
transfer transition but that a coordinated thiol cannot. 
A ferrous porphyrin dioxygen complex with an 
axial thiolate ligand has been reported [33] having an 
absorption spectrum substantially different from 
oxyP450,, . This led them to conclude that 
oxy-P-450_ does not have a thiolate ligand. The 
close similarity of their spectrum to those of thiol 
adducts of ferric P450 [ 1,19,34] and of a bis-thiolate 
ferric porphyrin complex [35], however, likely means 
that their complex [33] is a ferric species resulting 
from oxidation by dioxygen. 
Thus, the identity of the axial ligand trans to oxy- 
gen in oxy-P450, is uncertain. The MCD spectra 
of oxyP-450_ and oxymyoglobin obtained here 
(fig.1) are strikingly dissimilar. The spectrum of 
oxymyoglobin consists of three derivative shaped 
curves at 577 nm, 549 nm and 418 nm which have 
been assigned as Faraday A terms [23]. The spectrum 
of oxy-P450_, which cannot be properly assigned 
without examination of the effect of temperature, is 
considerably more complex and noticeably less intense 
than that of oxymyoglobin. In the 470-620 nm 
region, two symmetrically-shaped negative peaks and 
a complicated positive peak are seen. While the nega- 
tive peak at 561 nm may be part of a weak Faraday A 
term, the other features most certainly are not. In the 
320-470 nm Soret region, two symmetrical derivative- 
shaped curves of opposite sign (positive then negative 
as the wavelength decreases) to the single Soret feature 
seen in oxymyoglobin are found centered at 380 nm 
and 438 nm. Neither transition is centered at 4 18 nm, 
the absorption maximum of oxyP-450,,,, as would 
be expected for a simple Faraday A term. An addi- 
tional positive peak is seen centered at 337 nm. 
Because it is very unlikely that two identical chromo- 
phoric systems could have such different MCD spectra, 
it can at least be concluded that oxyP-450,,, does 
not have an axial neutral histidine ligand. 
The most reasonable remaining possibility is that 
oxy-P-450 has either an axial thiol or thiolate ligand. 
Coordination by imidazolate is also conceivable [36], 
but seems unlikely due to the rather weak acidity of 
neutral imidazole [37] even after coordination to 
iron [36,38]. The conclusion [27] that oxyP-450_ 
does have a neutral imidazole ligand tram to dioxygen 
was based on the spectral similarity between 
oxyP-450_ and oxyhemoglobin (oxymyoglobin) 
and the differences seen between the spectra of 
oxy-P450_ and the oxygen complex [33]. As dis- 
cussed above, these two interpretations are very likely 
incorrect. 
In conclusion, we have obtained evidence from an 
MCD spectral examination of oxyP450,, and 
oxymyoglobin against the presence of an axial neutral 
histidine ligand to iron trans to the dioxygen of 
oxyP-450_. Arguments have also been presented 
to show that the data which to the conclusion [27] 
that neutral histidine is the ligand are incorrect. Deter- 
mination of the true axial ligand awaits further experi- 
mentation including the preparation of a synthetic 
porphyrin model complex whose properties reproduce 
those of oxyP-450_. 
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